Epidemiology of Shigella sonnei and Shigella flexneri in the Global Pediatric Diarrhea Surveillance network, 2017-2022
Liu, J.; Lewontin, M.; Elwood, S. E.; Iyer, S. S.; Antoni, S.; Rey-Bonito, G.; Ortiz, C.; Weldegebriel, G.; Biey, J.; Mwenda, J. M.; Pastore, R.; Videbaek, D.; Singh, S.; Njambe, E.; Sangal, L.; Dhongde, D.; Grabovac, V.; Logronio, J.; Fahmy, K.; Ghoniem, A.; Armah, G.; Dennis, F. E.; Seheri, M. L.; Magagula, N.; Rakau-Nondela, K.; Fumian, T. M.; Maciel, I. T. A.; Samoilovich, E.; Semeiko, G.; Varghese, T.; Thomas, S.; Bines, J. E.; Li, D.; Kabir, F.; Houpt, E. R.; Mulders, M. N.; Soeters, H. M.; Platts-Mills, J. A.
Show abstract
Background Shigella is a leading cause of diarrhea in children in low- and middle-income countries (LMICs). Optimizing the impact of vaccines necessitates an accurate characterization of Shigella serotype prevalence. We describe the burden, epidemiology and characteristics of S. sonnei and S. flexneri diarrhea in the Global Pediatric Diarrhea Surveillance (GPDS) network. Methods GPDS is a World Health Organization-coordinated surveillance network investigating the etiology of hospitalized diarrhea among children aged <5 years. GPDS enrolls children hospitalized with diarrhea at 38 sentinel surveillance sites in 31 LMICs. Randomly selected stool specimens from these children were tested by quantitative polymerase chain reaction to detect a broad range of enteropathogens as well as to identify S. sonnei and S. flexneri serotypes. We estimated pathogen-specific attributable fractions and incidence of diarrheal hospitalizations. Results During 2017-2022, GPDS enrolled 70,750 children aged <5 years hospitalized with diarrhea, of which 16,458 (23.3%) were randomly selected for qPCR testing. Globally, Shigella caused 9.8% (95% Confidence Interval [CI]: 8.4, 11.3) of hospitalized diarrhea, with 28.3% of cases occurring in children aged {pound}12 months. The estimated attributable incidence of Shigella-associated diarrhea hospitalizations decreased from 1.27 (95% CI: 0.95, 1.64) per 1,000 child years in 2017-2018 to 0.88 (0.67, 1.10) in 2021-2022. Among typeable Shigella cases, 34.8% were S. sonnei, 24.2% were S. flexneri 2a, and 9.9% were S. flexneri 1b. Vaccines currently in development would cover an estimated 59.0% to 72.2% of cases. Conclusions These findings support the role of Shigella as an important cause of the most severe diarrhea in young children. The breadth of homotypic protection provided by Shigella vaccines in clinical development varied by region, and these broadly representative data can aid in prioritization. Non-dysenteric Shigella could not be readily differentiated from other causes of hospitalized diarrhea based on clinical characteristics.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: evidence from the Global Enteric Multicenter Study 96%
- Clinical predictors for etiology of acute diarrhea in children in resource-limited settings 94%
- The seasonality of diarrheal pathogens: A retrospective study of seven sites over three years 94%
Similar papers in this journal
- Defining severe shigellosis in the Enterics for Global Health study: A comparison of leading diarrhea severity definitions among children with Shigella diarrhea 96%
- Immunogenicity of a third scheduled dose of rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a phase IV, double-blind, randomised, placebo-controlled clinical trial 89%
- Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases from Household Microbiological and Clinical Data 89%
Similar papers in this journal
- Etiologies of bloody diarrhea in children presenting with acute gastroenteritis to US emergency departments 92%
- Epidemiology of pediatric astrovirus gastroenteritis in a Nicaraguan birth cohort 91%
- Setting a course for preventing hepatitis E in low and lower-middle-income countries: A systematic review of burden and risk factors 90%
Similar papers in this journal
- Clinical Impact of Multiplex Molecular Diagnostic Testing in Children with Acute Gastroenteritis Presenting to An Emergency Department: A Multicenter Prospective Study 92%
- Megasphaera in the stool microbiota is negatively associated with diarrheal cryptosporidiosis 90%
- Burden of lower respiratory tract infections preventable by adult immunization with 15- and 20-valent pneumococcal conjugate vaccines in the United States 90%
Similar papers in this journal
- Impact of Asymptomatic Enteroaggregative Escherichia coli Infection and Co-Pathogen Burden on Intestinal Barrier Function, Linear Growth, and Cognitive Development in Early Childhood: Insights from a Birth Cohort Study 93%
- Pervasive Intestinal Carriage with Multiple Species of Extended Spectrum Cephalosporin-Resistant Enterobacterales in Children Admitted for Severe Acute Malnutrition at a Tertiary Hospital in Malawi 92%
- Retrospective Review of Blood Culture-Confirmed Cases of Enteric Fever in Navi Mumbai, India: 2014–2018 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.